Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TBC1D13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PLXNA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VPS37B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRKACB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PMS2CL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLCN7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927523 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SCRG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC440982 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HELQ - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLECL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXL6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC35G2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR6831 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FTCD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GZF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC732360 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on